Navigation Links
Drug Combo May Relieve MS Symptoms

Adding steroid to multiple sclerosis treatment shows promise in study

THURSDAY, April 30 (HealthDay News) -- Using a steroid drug in combination with a multiple sclerosis (MS) drug may give patients more relief from symptoms than using the MS drug alone, suggests a new study.

In the study, which included 341 people with relapsing-remitting MS, some patients were randomly selected to receive the steroid drug methylprednisolone in three doses over three days once a month, in addition to regular treatment with the MS drug interferon beta-1a. Others received the interferon drug and a placebo.

During the three-year study, the patients were assessed every three months. Those who took the steroid/interferon drug combination had 38 percent fewer relapses (episodes when the disease is active) than those who took the placebo and interferon, the study found. The patients in the steroid/interferon group also showed slight improvement on a test of MS disability, while those in the placebo/interferon group showed a slight decline.

The Biogen Idec-supported study also found that MS-related brain lesions stayed the same size or shrank in the steroid/interferon group but grew larger in the placebo/interferon group. The findings were presented this week at the annual meeting of the American Academy of Neurology, in Seattle.

"These results indicate that these two drugs may have a synergy when taken together and provide a more beneficial effect on the disease activity," study author Dr. Mads Ravnborg, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark, said in an American Academy of Neurology news release. "This is a promising finding, as the benefit from interferon is only moderate, and not everyone responds fully to the treatment, so anything we can do to boost those results is positive."

More information

The National Multiple Sclerosis Society has more about MS treatments.

-- Robert Preidt

SOURCE: American Academy of Neurology, news release, April 30, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Radiation and drug combo helps boost efficacy of lung cancer treatment
2. Aerobic, Weight Training Combo Best Against Diabetes
3. New antibiotic drug combo to speed up treatment of tuberculosis
4. Drug Combo Helps Fight Marfan Syndrome
5. Drug Combo Blocks Pain Without Impairing Movement
6. Two-Drug Combo Fights Brain Tumors
7. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
8. Drug Combo Boosts Multiple Myeloma Survival
9. Drug Combos Effective Against Rheumatoid Arthritis
10. Combo PET/CT Scan Helps Spot Breast Cancers Spread
11. Drug Combo With Antibiotic May Slow MS Progression
Post Your Comments:
Related Image:
Drug Combo May Relieve MS Symptoms
(Date:12/1/2015)... ... 01, 2015 , ... Tympani Inc., announced today that it ... Cisco. This designation recognizes Tympani as having fulfilled the training requirements and program ... the high-end enterprise contact center marketplace. , Ed Kapelinski, President of Tympani stated, ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National Association of ... into its VIP Woman of the Year Circle. She is recognized with this ... exclusively for professional women, boasting 850,000 members and over 200 operating Local Chapters. ...
(Date:11/30/2015)... ... November 30, 2015 , ... Being a caregiver ... the VA Maryland Health Care System, the Caregiver Support Program promotes the health ... a difficult job. Seventy-four percent report that their role as a caregiver has ...
(Date:11/30/2015)... TX (PRWEB) , ... November 30, 2015 , ... ... plastic surgery and dermatology, is proud to announce that its ThermiRFR temperature controlled ... , ThermiRF is an innovative multi-application radiofrequency platform which uses temperature as a ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... and fun atmosphere for Halloween festivities, the Word of Life Christian Church of ... board game, and featuring a giant 1.25 ton pile of candy dubbed “Candy ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 /PRNewswire/ ... its wholly-owned UK subsidiary Proximagen Ltd., today announced a ... oral small molecule inhibitor of Vascular Adhesion Protein 1 ... the treatment of inflammatory disease. The VAP-1 inhibitor is ... --> --> Under the terms of ...
(Date:11/30/2015)... TOKYO , 1 décembre 2015 ... plus grande exposition et conférence d,Asie ... médicaux et sur l,industrie manufacturière, se ... du 20 au 22 avril ... - Photo - ...
(Date:11/30/2015)... 2015 --> ... - Pipeline Review, H2 2015" market research ... pipeline of Endometriosis and helps enhance decision ... to gain competitive advantage. It strengthens R&D ... to produce first-in-class and best-in-class products. ...
Breaking Medicine Technology: